Potential financial conflict of interest: D. Vinh is supported by the Clinician-Scientist Scholar Junior 2 program of the Fonds de la recherche en santé du Québec and has received research support from Cidara Therapeutics, CSL Behring and Janssen Pharmaceutical, and consulting or speaker honoraria from CSL Behring, Novartis Canada, and UCB Biosciences GmbH. None of these entities were involved in any aspect of the research in this manuscript. D. Vinh has a patent application pending (EFS ID: 40101099), unrelated to the research in this manuscript. M. Ndao reports having filed on April 2, 2019 the McGill report of invention ROI 2019-107, unrelated to the research in this manuscript. A report of invention has been submitted by D. Vinh, on behalf of D. Vinh, M. Golizeh, and M. Ndao, to McGill University for the work in this manuscript (Track code: D2021-0043). 10 V. Loo has received consulting fees for Merck Canada Inc.